Abbott receives FDA EUA for test that detects SARS-CoV-2 and three other respiratory infections
The test helps save on much-needed testing supplies since it allows for testing for all four viruses with one swab
The test helps save on much-needed testing supplies since it allows for testing for all four viruses with one swab
Industry experts share insights on the elegant technology behind immunoassays and the critical raw materials that make them powerful
Simple, powerful user experience combines with reliability and scalability allowing users to focus on experimental results instead of process
For the first time Astronomy and Pathology (AstroPath™) come together to discover and clinically validate new spatial phenotypic signatures using multiplex immunofluorescence
Funding will advance 3D lung cell culture models to accelerate drug discovery
Discovery is a result of Abbott's continued virus hunting efforts, which also uncovered a new strain of HIV in 2019
The partnership will pair Personalis’ NeXT tumor profiling with Natera’s Signatera™ for treatment monitoring
Collaboration agreement to market AZOVA COVID-19 test collection kit online
Explore hot topics from 3D X-ray microscopy and in vitro diagnostics to gas chromatography and synthetic guide RNAs
The update provides alternative temperature for transportation and temporary storage for frozen vials before dilution
SARS-CoV-2 testing is a powerful tool for curbing the COVID-19 pandemic and safely reopening schools and businesses
Opaganib demonstrated dual anti-inflammatory and antiviral activity and targets a human cell component involved in viral replication
The license from ERS expands ZeClinics CRISPR IP portfolio and increases the validity and potency of zebrafish models for the drug discovery process
Catch up on part one of our exclusive webinar series to hear Dr. Frank Peacock dispel the four lies of high-sensitivity troponin